CAPA to Present Two Posters at the 2026 CRA Annual Scientific Meeting

The Canadian Arthritis Patient Alliance is pleased to be presenting two posters at the 2026 Canadian Rheumatology Association Annual Scientific Meeting, taking place April 16–19 in Halifax. CAPA’s President, Linda Wilhelm, will be attending the conference and...

CAPA’s Letter to the Federal Government on New Co-Payments Under the Interim Federal Health Program (IFHP)

[et_pb_section fb_built="1" _builder_version="4.16" global_colors_info="{}"][et_pb_row _builder_version="4.16" background_size="initial" background_position="top_left" background_repeat="repeat" global_colors_info="{}"][et_pb_column type="4_4" _builder_version="4.16"...

Broken Chains: Understanding Drug Shortages and Their Impact on Patients

Drug shortages are an ongoing and growing challenge in Canada—affecting not just supply chains, but the daily lives of people who rely on medications to stay well. Join the Canadian Arthritis Patient Alliance (CAPA) for a one-hour discussion on Wednesday, May 13, 2026...

Getting on a Biologic Medication

We invite you to an free webinar “Getting on a Biologic Medication” on Tuesday, March 31, 2026 at 6:00 PM EDT to explore the journey and steps involved in starting a biologic medication for arthritis—from the initial conversation with a rheumatologist...

CAPA’s Letter to the Minister of Health on COVID-19 Vaccine Choice

[et_pb_section fb_built="1" _builder_version="4.16" global_colors_info="{}"][et_pb_row _builder_version="4.16" background_size="initial" background_position="top_left" background_repeat="repeat" global_colors_info="{}"][et_pb_column type="4_4" _builder_version="4.16"...